Thermogenesis Holdings to Participate at the H.C. Wainwright BIOCONNECT 2021 Conference

Rhea-AI Summary

ThermoGenesis Holdings, Inc. (Nasdaq: THMO) announced that CFO Jeff Cauble will present a company overview at the H.C. Wainwright BIOCONNECT 2021 Conference on January 11 at 6:00 am ET. The presentation will be accessible on ThermoGenesis' website and archived for 90 days. The company specializes in automated technologies for CAR-T and cell-based therapies, offering a range of solutions for clinical biobanking and immuno-oncology. For further details, visit their website.

RANCHO CORDOVA, Calif., Jan. 7, 2021 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO) a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that Jeff Cauble, Chief Financial Officer, will present a company overview at the H.C. Wainwright BIOCONNECT 2021 Conference.

The presentation will be available beginning January 11, at 6:00 am ET, on the ThermoGenesis website at: https://thermogenesis.com/investors/news-and-events/events-webcasts and will be archived for a period of 90 days after the conference.

About ThermoGenesis Holdings, Inc.
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for CAR-T and other cell-based therapies. The Company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress™ platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. For more information about ThermoGenesis, please visit: www.thermogenesis.com.

Company Contact: 
Wendy Samford
916-858-5191
ir@ThermoGenesis.com

Investor Contact: 
Paula Schwartz, Rx Communications
917-322-2216
pschwartz@rxir.com

 

View original content:http://www.prnewswire.com/news-releases/thermogenesis-holdings-to-participate-at-the-hc-wainwright-bioconnect-2021-conference-301202614.html

SOURCE ThermoGenesis Holdings, Inc.

FAQ

When will ThermoGenesis Holdings present at the H.C. Wainwright BIOCONNECT 2021 Conference?

ThermoGenesis Holdings will present on January 11, 2021, at 6:00 am ET.

Where can I watch the ThermoGenesis Holdings Conference presentation?

The presentation will be available on the ThermoGenesis website at this link: https://thermogenesis.com/investors/news-and-events/events-webcasts.

What technologies does ThermoGenesis Holdings specialize in?

ThermoGenesis specializes in automated technologies for CAR-T and other cell-based therapies.

Who is presenting for ThermoGenesis Holdings at the conference?

CFO Jeff Cauble will present on behalf of ThermoGenesis Holdings.

How long will the ThermoGenesis Holdings presentation be archived?

The presentation will be archived for 90 days after the conference.